{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:54:47Z","timestamp":1784548487283,"version":"3.55.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.annder.2013.09.158","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T17:45:49Z","timestamp":1381772749000},"page":"801-802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["D\u00e9veloppement d\u2019un vitiligo au cours du traitement d\u2019une spondylarthrite ankylosante par adalimumab"],"prefix":"10.1016","volume":"140","author":[{"given":"\u00c9.","family":"Toussirot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Salard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-P.","family":"Algros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2013.09.158_bib0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/03009740902922612","article-title":"Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors","volume":"38","author":"Exarchou","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.annder.2013.09.158_bib0010","doi-asserted-by":"crossref","first-page":"e52298","DOI":"10.1371\/journal.pone.0052298","article-title":"Increased tumor necrosis factor (TNF)-\u03b1 and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo","volume":"7","author":"Laddha","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.annder.2013.09.158_bib0015","doi-asserted-by":"crossref","first-page":"e18907","DOI":"10.1371\/journal.pone.0018907","article-title":"Th17\u00a0cells and activated dendritic cells are increased in vitiligo lesions","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.annder.2013.09.158_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/15569527.2011.560913","article-title":"Tumor necrosis factor-\u03b1 in vitiligo: direct correlation between tissue levels and clinical parameters","volume":"30","author":"Kim","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.annder.2013.09.158_bib0025","first-page":"534","article-title":"Treatment of generalized vitiligo with anti-TNF-\u03b1 agents","volume":"11","author":"Alghamdi","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.annder.2013.09.158_bib0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000324619","article-title":"Vitiligo during treatment of Crohn's Disease with Adalimumab: adverse effect or co-occurrence?","volume":"3","author":"Posada","year":"2011","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.annder.2013.09.158_bib0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajg.2011.03.001","article-title":"Vitiligo in a patient receiving infliximab for refractory ulcerative colitis","volume":"12","author":"Ismail","year":"2011","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.annder.2013.09.158_bib0040","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.jaad.2006.05.035","article-title":"Vitiligo after the resolution of psoriatic plaques during treatment with adalimumab","volume":"58","author":"Smith","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2013.09.158_bib0045","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3899\/jrheum.100968","article-title":"Vasculitis, vitiligo, thyroiditis, and altered hormone levels after anti-tumor necrosis factor therapy","volume":"38","author":"Lahita","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2013.09.158_bib0050","first-page":"313","article-title":"Association between vitiligo and spondyloarthritis","volume":"28","author":"Padula","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2013.09.158_bib0055","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.revmed.2010.02.007","article-title":"TNF-alpha blocking agent and sarcoidosis: an update","volume":"31","author":"Toussirot","year":"2010","journal-title":"Rev Med Interne"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963813010879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963813010879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:01:09Z","timestamp":1758970869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963813010879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0151963813010879"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2013.09.158","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D\u00e9veloppement d\u2019un vitiligo au cours du traitement d\u2019une spondylarthrite ankylosante par adalimumab","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2013.09.158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}